BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

8668 related articles for article (PubMed ID: 1697409)

  • 1. Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53.
    Chenevix-Trench G; Martin NG; Ellem KA
    Oncogene; 1990 Aug; 5(8):1187-93. PubMed ID: 1697409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma.
    Loganzo F; Dosik JS; Zhao Y; Vidal MJ; Nanus DM; Sudol M; Albino AP
    Oncogene; 1993 Oct; 8(10):2637-44. PubMed ID: 7690926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of c-kit expression in cultured melanoma cells.
    Lassam N; Bickford S
    Oncogene; 1992 Jan; 7(1):51-6. PubMed ID: 1371338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
    Whitman MM; Shen YM; Soprano D; Soprano KJ
    Cancer Res; 1990 Jun; 50(11):3193-8. PubMed ID: 2139801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of c-myc mRNA levels by insulin or platelet-poor plasma.
    Gai XX; Rizzo MG; Valpreda S; Baserga R
    Oncogene Res; 1989; 5(2):111-20. PubMed ID: 2691956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor necrosis factor stimulates proliferation of human osteosarcoma cells and accumulation of c-myc messenger RNA.
    Kirstein M; Baglioni C
    J Cell Physiol; 1988 Mar; 134(3):479-84. PubMed ID: 2450880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered gene expression of c-myc, epidermal growth factor receptor, transforming growth factor-alpha, and c-erb-B2 in an immortalized human breast epithelial cell line, HMT-3522, is associated with decreased growth factor requirements.
    Madsen MW; Lykkesfeldt AE; Laursen I; Nielsen KV; Briand P
    Cancer Res; 1992 Mar; 52(5):1210-7. PubMed ID: 1737382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the protein tyrosine kinase c-Yes but not c-Src by neurotrophins in human brain-metastatic melanoma cells.
    Marchetti D; Parikh N; Sudol M; Gallick GE
    Oncogene; 1998 Jun; 16(25):3253-60. PubMed ID: 9681823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene expression in adenocarcinomas of the colon and in colon tumor-derived cell lines.
    Untawale S; Blick M
    Anticancer Res; 1988; 8(1):1-7. PubMed ID: 3282475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M; Janz I; Wintzer HO; Wagner E; Bauknecht T
    Anticancer Res; 1989; 9(6):1537-47. PubMed ID: 2697181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terminal differentiation in a non-small-cell bronchopulmonary carcinoma correlates with increased expression of p53.
    Liscia E; Riou D; Slavoshian S; Boesch S; Lebert V; Tomasoni C; Dabouis G; Biard JF; Roussakis C
    Anticancer Res; 1996; 16(3A):1209-12. PubMed ID: 8702238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle dependent growth factor regulation of gene expression.
    Morgan CJ; Pledger WJ
    J Cell Physiol; 1989 Dec; 141(3):535-42. PubMed ID: 2512304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
    Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
    J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-myc expression correlates with suppression of c-kit protooncogene expression in small cell lung cancer cell lines.
    Plummer H; Catlett J; Leftwich J; Armstrong B; Carlson P; Huff T; Krystal G
    Cancer Res; 1993 Sep; 53(18):4337-42. PubMed ID: 7689933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
    Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
    Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
    Richon VM; Ramsay RG; Rifkind RA; Marks PA
    Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C; Modjtahedi N; Lamonerie T; Frebourg T; Landin RM; Fossar N; Lhomond G; Cassingena R; Brison O
    Anticancer Res; 1989; 9(5):1265-79. PubMed ID: 2686529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor alpha genes in chemically transformed rat liver epithelial cells.
    Lee LW; Raymond VW; Tsao MS; Lee DC; Earp HS; Grisham JW
    Cancer Res; 1991 Oct; 51(19):5238-44. PubMed ID: 1717143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 434.